Wells Fargo
CLBT icon

Wells Fargo’s Cellebrite CLBT Stock Holding History

Wells Fargo’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$1.85M – 7149
2025
Q3 		$1.85M Buy
+100,000
New +$1.57M ﹤0.01% 3365

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo's CLBT Position: Q1 2026 in Review

Wells Fargo increased its Cellebrite (CLBT) stake by 9.5% in Q1 2026, buying an estimated $80.1K and bringing the position to 60,977 shares worth $840K. The position accounts for ﹤0.01% of the portfolio, ranked #3838.

Wells Fargo first reported a position in CLBT in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.21M in Q4 2024. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Wells Fargo held 60,977 shares of Cellebrite worth $840K as of Q1 2026.
  • Wells Fargo bought 5,313 Cellebrite shares in Q1 2026, an estimated $80.1K.
  • Cellebrite made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3838 holding.
  • Wells Fargo first reported a position in Cellebrite in Q4 2023 and has held it in 8 quarters since.
  • Wells Fargo's Cellebrite position peaked at $1.21M in Q4 2024.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.